Streetbeat News

Products Services

ENSC

Ensysce Biosciences Inc (NASDAQ:ENSC) received an FDA Breakthrough Therapy Designation for its opioid PF614-MPAR, designed to provide pain relief while preventing overdose. The designation, granted to fewer than 300 drugs, will expedite the drug's development and review. ENSC's stock rose 42.20% to $1.62 following the news.

Portfolio Pulse from Vandana Singh

January 23, 2024 | 6:13 pm

BAH

EADSF

EADSY

PLTR

XOM

Palantir Technologies Inc (NYSE:PLTR) is experiencing a slowdown in revenue growth from U.S. government contracts, leading to a decline in its stock market performance. RBC Capital Markets and Jefferies analysts point to government agencies preferring more cost-effective solutions, while William Blair notes increasing competition in defense contracts. Palantir's CEO Alex Karp is focusing on the company's new AI platform for future growth, despite skepticism from some investors. The company has also faced challenges with data privacy in Europe and a potential breach of contract with the U.K.'s NHS. Palantir's stock has gained over 138% last year but is currently trading lower by 1.65% to $17.31.

Portfolio Pulse from Anusuya Lahiri

January 23, 2024 | 6:04 pm

ETHUSD

A total of 3,816.45 Ether (ETH) worth approximately $8.43 million was burned on Monday, permanently removing it from circulation. This is a result of the EIP-1159 upgrade implemented on August 5th, 2021, which introduced a variable base fee for transactions that is burned. The current issuance rate of new Ether is 4% per year, expected to drop to 0.5-1% with the Ethereum 2.0 upgrade, potentially making ETH a deflationary currency. The net annualized issuance rate for Ether was -2.23% yesterday.

Portfolio Pulse from Benzinga Insights

January 23, 2024 | 6:00 pm

RVSN

Rail Vision Ltd. (NASDAQ:RVSN) stock surged after announcing its Main Line system received EU railway standards certifications. This achievement is seen as a major milestone, positioning Rail Vision ahead in the railway technology market. The company also recently entered the US market with a $5 million contract for its AI-based Switch Yard Systems. Rail Vision's stock is trending with heavy trading volume, significantly exceeding its 100-day average.

Portfolio Pulse from Erica Kollmann

January 23, 2024 | 5:58 pm

RVSN

Rail Vision's stock (RVSN) is experiencing an increase in value due to the positive momentum following the announcement that its Main Line system has received formal certifications for key European Union railway standards.

Portfolio Pulse from Benzinga Newsdesk

January 23, 2024 | 5:56 pm

ALC

CZMWY

Bernstein analyst Susannah Ludwig has initiated coverage on ophthalmology companies, recommending Alcon AG (NYSE:ALC) with an Outperform rating and a price target of $94.03, while giving Carl Zeiss Meditec AG (OTC:CZMWY) an Underperform rating with a price target of $82.31. Ludwig highlights the importance of innovation in the ophthalmology market, which is valued at $34 billion with mid-single digit growth rates. Alcon is noted for its significant R&D spending, which is 1.9 times higher than its next competitor, while Zeiss, though leading in digital, must maintain high R&D spending to stay competitive. Shares of Alcon and Carl Zeiss Meditec declined by 2.34% and 0.95%, respectively, at the time of publication.

Portfolio Pulse from Priya Nigam

January 23, 2024 | 5:47 pm

GOOG

GOOGL

Google has announced the introduction of experimental generative AI features in the latest release of Chrome (M121), which will be available for users to try on Macs and Windows PCs in the U.S. over the next few days.

Portfolio Pulse from Benzinga Newsdesk

January 23, 2024 | 5:00 pm

RUM

Rumble's stock price has increased following the announcement of a partnership with Barstool Sports and the public launch of Rumble Studio.

Portfolio Pulse from Benzinga Newsdesk

January 23, 2024 | 4:53 pm

NVO

EraCal Therapeutics has entered into a collaboration with Novo Nordisk to develop and commercialize EraCal's oral small molecule program for treating obesity. The deal includes upfront, development, and commercial milestones that could total up to €235 million.

Portfolio Pulse from Benzinga Newsdesk

January 23, 2024 | 4:47 pm

NVVE

Nuvve Holding Corp. (NASDAQ:NVVE) shares surged after the company was awarded a $16 million project to implement a turnkey fleet electrification program for Fresno EOC's 50-shuttle fleet using its proprietary software and V2G technology. Additionally, Nuvve recently executed a 1-for-40 reverse stock split, reducing its outstanding shares from approximately 49.9 million to about 1.3 million. NVVE shares are up 44.77% to $4.31.

Portfolio Pulse from Nabaparna Bhattacharya

January 23, 2024 | 4:45 pm